Apparently, E-/P-selectin deficiency in the tumor stroma creates a previously unknown vulnerability of TCs to additional ITGB4 depletion, which was also suggested by increased ITGB4 expression in the xenograft tumors in E-/P-selectin KO mice in several of the tested models. The gene discussed is ITGB4; the disease is neoplasm.